← SynDRA
DESERPIDINE
SynDRA canonical compound SYN0023036 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | SLC18A2 |
|---|
| Mechanism of action | Angiotensin converting enzyme inhibitor |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- ACE inhibitor
- SLC18A2 INHIBITOR
- Synaptic vesicular amine transporter inhibitor
- SLC33A1 INHIBITOR
Drug classes
- Catecholamine-depleting Sympatholytic
ATC classes
- C02A · ANTIADRENERGIC AGENTS, CENTRALLY ACTING
- ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION
Cross-references
Synonyms
- deserpidin
- raunormin
- raunormine
- recanescin
- recanescine
- reserpidine
- Deserpidina
- Deserpidine, (-)-
- Halmonyl
- NSC-72138
- Deserpidine component of enduronyl
- Deserpidine component of oreticyl forte
- Harmonyl
- Canescin
- Canescine
- Deresperine
- Desepridine
- Deserpidin
- Deserpidinum
- Desmethoxyreserpine
- Raunormin
- Raunormine
- Recanescin
- Recanescine
- Reserpidine
- Tranquinil
- Lilly 22641
- ORETICYL 50
- A-11025
- Deserpidina [INN-Spanish]
- Deserpidine (INN)
- Deserpidine [INN:BAN]
- Deserpidinum [INN-Latin]
- Halmonyl (TN)
- MD-0232
- Deserpidic acid, methyl ester, 3,4,5-trimethoxybenzoate
- Methyl 17alpha-methoxy-18beta-(3,4,5-trimethoxybenzoyloxy)-3beta,20alpha-yohimban-16beta-carboxylat
- Methyl 17alpha-methoxy-18beta-((3,4,5-trimethoxybenzoyl)oxy)-3beta,20alpha-yohimban-16beta-carboxylate
Look up DESERPIDINE in the interactive SynDRA portal →